A recent report published by Infinium Global Research on the human vaccines market provides an in-depth analysis of segments and sub-segments in the global as well as regional human vaccines market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional human vaccines market over the short term as well as long term. The report is a comprehensive presentation of trends, forecasts, and dollar values of the global human vaccines market. According to the report, the global human vaccines market is projected to grow at a CAGR of 10% over the forecast period of 2022-2028.

Market Insight

The value of the human vaccines market in 2022 was USD 69 billion and is expected to reach USD 120 billion in 2028 and is expected to be growing with a CAGR of more than 10%. Human vaccines are biological preparations that have the potential to increase immunity to certain human diseases. Both bacterial and viral diseases have vaccinations available for humans. Human vaccinations can be administered via aerosol, injection, or oral administration. Vaccines contain chemicals that look like disease-causing bacteria. Microbial components, weakened microorganisms, or dead microbes are infused in vaccinations to prevent them from causing disease. When vaccines are injected into the body, the immune system of the individual will fight the pathogens and quickly eliminate them. Human vaccines find application against illnesses such as chickenpox, diphtheria, hepatitis, hepatitis, human papillomavirus, influenza, measles, meningococcal, mumps, polio, pertussis, pneumococcal, rabies, rotavirus, smallpox, tetanus, yellow fever, zoster, and some others. Human vaccines are available for adolescents, adults, geriatric, and pediatric age groups.

While the covid-19 pulverized the businesses and markets around the world. It catapulted the human vaccines market. Implementation of lockdowns, physical restrictions, and social distancing guidelines was introduced to contain the spread of the covid-19 pandemic. All these measures were necessary but temporary. The only way to end the covid-19 pandemic was to create a vaccine for it and increase the immunity of people. It was the first time that a vaccine for a disease was made in a record time of less than a year and cleared its way to the market. There were many companies that developed covid-19 vaccines. The demand for the covid-19 vaccine was in billion doses. Thus, the covid-19 pandemic greatly aided the growth of the market. The high occurrences of various viral and bacterial diseases are driving the growth of the global human vaccines market. The intervention of governments as well as other non-governmental agencies through various awareness campaigns is aiding the increasing awareness about the benefits of human vaccines among the public worldwide. The increase in awareness is expected to enhance the growth of the human vaccines market, as it prompts more people to seek vaccinations. The compulsory and non-compulsory vaccination as part of immunization programs for children against certain diseases is expected to drive the growth of the global human vaccines market, as these vaccines are essential to prevent some of the eradicated diseases from re-emerging. Moreover, the assurance from major health organizations such as WHO and AMA drives the adoption of human vaccines significantly and it is expected to drive the growth of the global human vaccines market during the forecast period. Stringent regulations set by various countries and high costs associated with research and development are expected to restrain the market. Opportunities are expected to be there for the major players to expand in the developing and poor economies as governments focus on immunization programmers against various diseases during the forecast period.

North America leads the global human vaccines market due to the increasing number of patients with cancers. Furthermore, infectious diseases are increasing considerably in countries such as Canada and USA. Huge investments from governments for vaccine research and immunization programmers drive the North American human vaccines market. The presence of major pharmaceutical companies’ research & development and production facilities for human vaccines drive the European region into the second-largest human vaccines market. A significant portion of the human vaccines manufactured in Europe is exported to other regions. However, the vaccination programs conducted by various healthcare services in European countries drive the demand for human vaccines in the European region. The presence of a large population in countries such as China and India drives the growth of the Asia-Pacific human vaccines market. The Asia-Pacific region is expected to emerge as the fastest-growing market due to the government support and investment in immunization programs in various countries.

Segment Covered

The report on the global human vaccines market covers segments such as product and disease type. On the basis of product, the sub-markets include live attenuated vaccines, killed vaccines, conjugate vaccines, synthetic vaccines, and others. On the basis of disease type, the sub-markets include pneumonia, influenza, hepatitis, HPV, and others.

Companies Profiled:

The report provides profiles of the companies in the market such as GlaxoSmithKline Plc, CSL Limited, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Tadeka Pharmaceutical Company Limited, Emergent BioSolutions, Inc., Bavarian Nordic, Sanofi Pasteur, and Serum Institute of India Pvt Ltd.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the human vaccines market. Moreover, the study highlights current market trends and provides forecasts for 2022-2028. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.